CD44 splice variants: metastases meet lymphocytes
- 31 August 1993
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 14 (8), 395-399
- https://doi.org/10.1016/0167-5699(93)90141-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Lymphocyte interactions with endothelial cellsImmunology Today, 1992
- Roll, roll, roll your leucocyte gently down the vein.Immunology Today, 1992
- Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.The Journal of cell biology, 1992
- Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein.The Journal of Experimental Medicine, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.The Journal of Experimental Medicine, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987
- The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune SystemAnnual Review of Immunology, 1987
- Production of Self-directed Antibody by Tumour CellsNature, 1968